Llama antibodies offer a unique alternative to conventional polyclonal antibodies, driven by the camelid immune system’s ability to generate small, highly stable antibody fragments known as nanobodies (vHHs). These antibodies exhibit strong specificity and affinity while maintaining exceptional stability under conditions that often compromise traditional antibodies.

LAMPIRE provides custom llama polyclonal antibody development programs designed around your antigen and application needs. Llama immunizations require smaller antigen quantities while delivering reliable, high‑performance antibodies suitable for research, diagnostic, and development workflows. With in‑house expertise spanning antigen design through purification, LAMPIRE supports consistent and reproducible antibody outcomes.